Download PDF
Klin Monbl Augenheilkd 2022; 239(04): 390-392
DOI: 10.1055/a-1785-4320
Der interessante Fall

Recurrent Corneal and Conjunctival Dysplasia in an Immunocompromised Patient – The Interesting Case

Rezidivierende Hornhaut- und Bindehautdysplasie bei einem immungeschwächten Patienten – der interessante Fall
Yasmine Derradji
Department of Ophthalmology, University Hospital Basel, Basel, Switzerland
,
Peter Meyer
Department of Ophthalmology, University Hospital Basel, Basel, Switzerland
,
Zisis Gatzioufas
Department of Ophthalmology, University Hospital Basel, Basel, Switzerland
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Background

Epithelial dysplasia is categorized as conjunctival/corneal intraepithelial neoplasia, which is a precancerous lesion and part of the spectrum of diseases called ocular surface squamous neoplasia (OSSN). The lesion usually develops at the limbal region of the interpalpebral conjunctiva. Main risk factors include ultraviolet light exposure, human papillomavirus (HPV) infection, and immunosuppression (HIV/AIDS). Surgical excision, usually with adjunctive cryotherapy, has been the traditional therapy for OSSN [1]. Because of a high recurrence rate after surgical excision [2], topical chemotherapy including mitomycin-C (MMC), 5-fluorouracil (5-FU), and interferon (IFN) has been used extensively [3], [4], [5]. Here, we report a case of recurrent conjunctival and corneal intraepithelial neoplasia.



Publication History

Received: 14 September 2021

Accepted: 27 February 2022

Article published online:
26 April 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Fraunfelder FT, Wingfield D. Therapy of intraepithelial epitheliomas and squamous cell carcinoma of the limbus. Trans Am Ophthalmol Soc 1980; 78: 290-300
    PubMedGoogle Scholar
  • 2 Yang J, Foster CS. Squamous cell carcinoma of the conjunctiva. Int Ophthalmol Clin 1997; 37: 73-85
    CrossrefPubMedGoogle Scholar
  • 3 Gupta A, Muecke J. Treatment of ocular surface squamous neoplasia with Mitomycin C. Br J Ophthalmol 2010; 94: 555-558
    CrossrefPubMedGoogle Scholar
  • 4 Frucht-Pery J, Sugar J, Sutphin JE. et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology 1997; 104: 2085-2093
    CrossrefPubMedGoogle Scholar
  • 5 Frucht-Pery J, Rozenman Y, Peʼer J. Topical mitomycin-c for partially excised conjunctival squamous cell carcinoma. Ophthalmology 2002; 109: 548-552
    CrossrefPubMedGoogle Scholar
  • 6 Tabin G, Levin S, Snibson G. et al. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology 1997; 104: 485-492
    CrossrefPubMedGoogle Scholar
  • 7 Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 2002; 133: 601-606
    CrossrefPubMedGoogle Scholar